Zonisamide - induced urinary lithiasis in patients with intractable epilepsy

被引:40
|
作者
Kubota, M
Nishi-Nagase, M
Sakakihara, Y
Noma, S
Nakamoto, M
Kawaguchi, H
Yanagisawa, M
机构
[1] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan
[2] Metropolitan Hachiouji Childrens Hosp, Dept Pediat, Tokyo, Japan
关键词
zonisamide; urinary lithiasis; epilepsy;
D O I
10.1016/S0387-7604(00)00118-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report here three patients with intractable epilepsy who developed urinary lithiasis during zonisamide (ZNS) treatment. Abdominal pain due to left-sided hydronephrosis was the initial symptom in the first patient, and it was resolved after the excretion of a stone. The second patient, who had no specific symptoms, was found to have a thick: sludge of calcium phosphate: in the bladder when he suffered from aspiration pneumonia and dehydration. The third patient, who had a history of recurrent urinary obstruction, was also found to have a thick sludge of calcium oxalate in the bladder. The urinalysis of the three patients revealed alkaline urine and hypercalciuria. Although their urinary lithiasis was resolved by discontinuation of ZNS and supportive therapy, routine examination of urine parameters such as pn and sediments, and daily urine-output cheeks are thought to be necessary during treatment with ZNS, especially for patients who are bedridden tor a long time and receive multiple antiepileptic drugs. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:230 / 233
页数:4
相关论文
共 50 条
  • [1] Retention rate of zonisamide in intractable epilepsy
    Nakken, K. O.
    Lindstrom, P.
    Andersen, H.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (05): : 268 - 274
  • [2] Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy
    Lee, Yun Jin
    Kang, Hoon Chul
    Seo, Joo Hee
    Lee, Joon Soo
    Kim, Heung Dong
    BRAIN & DEVELOPMENT, 2010, 32 (03) : 208 - 212
  • [3] Safety and tolerability of zonisamide in elderly patients with epilepsy
    Trinka, E.
    Giorgi, L.
    Patten, A.
    Segieth, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (06): : 422 - 428
  • [4] Zonisamide in the treatment of epilepsy
    Holder, J. Lloyd, Jr.
    Wilfong, Angus A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2573 - 2581
  • [5] Zonisamide for the treatment of epilepsy
    Arzimanoglou, Alexis
    Rahbani, Abdallah
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2006, 6 (09) : 1283 - 1292
  • [6] Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy
    Joo, Eun Yeon
    Kim, Sun Hwa
    Seo, Dae Won
    Hong, Seung Bong
    CLINICAL NEUROPHYSIOLOGY, 2008, 119 (06) : 1385 - 1392
  • [7] Zonisamide in the management of epilepsy in the elderly
    Romigi, Andrea
    Femia, Eti A.
    Fattore, Cinzia
    Vitrani, Giuseppe
    Di Gennaro, Giancarlo
    Franco, Valentina
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 931 - 937
  • [8] Safety and tolerability of zonisamide in paediatric patients with epilepsy
    Cross, J. Helen
    Auvin, Stephane
    Patten, Anna
    Giorgi, Luigi
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2014, 18 (06) : 747 - 758
  • [9] Long-term efficacy and safety of zonisamide monotherapy in epilepsy patients
    Park, Sung-Pa
    Kim, Sun-Young
    Hwang, Yang-Ha
    Lee, Ho-Won
    Suh, Chung-Kyu
    Kwon, Soon-Hak
    JOURNAL OF CLINICAL NEUROLOGY, 2007, 3 (04): : 175 - 180
  • [10] Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients
    Kim, Dong Wook
    Yoo, Moon-Won
    Park, Kyoung Sik
    EPILEPSY & BEHAVIOR, 2012, 23 (04) : 497 - 499